Harbor Capital Advisors Inc. Cuts Stock Holdings in HealthEquity, Inc. $HQY

Harbor Capital Advisors Inc. lowered its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 67.1% in the 3rd quarter, HoldingsChannel reports. The firm owned 16,021 shares of the company’s stock after selling 32,610 shares during the quarter. Harbor Capital Advisors Inc.’s holdings in HealthEquity were worth $1,518,000 as of its most recent SEC filing.

Several other hedge funds have also recently modified their holdings of the business. Farther Finance Advisors LLC raised its stake in HealthEquity by 232.4% in the second quarter. Farther Finance Advisors LLC now owns 246 shares of the company’s stock worth $26,000 after buying an additional 172 shares in the last quarter. WPG Advisers LLC purchased a new position in shares of HealthEquity in the 1st quarter valued at $28,000. Caitong International Asset Management Co. Ltd bought a new position in shares of HealthEquity in the 2nd quarter worth $33,000. Cullen Frost Bankers Inc. lifted its stake in shares of HealthEquity by 172.3% during the 2nd quarter. Cullen Frost Bankers Inc. now owns 354 shares of the company’s stock worth $37,000 after purchasing an additional 224 shares during the last quarter. Finally, Northwestern Mutual Wealth Management Co. lifted its stake in shares of HealthEquity by 176.4% during the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 655 shares of the company’s stock worth $58,000 after purchasing an additional 418 shares during the last quarter. Hedge funds and other institutional investors own 99.55% of the company’s stock.

Insiders Place Their Bets

In related news, EVP Elimelech Rosner sold 10,959 shares of the firm’s stock in a transaction dated Thursday, December 18th. The stock was sold at an average price of $95.45, for a total transaction of $1,046,036.55. Following the sale, the executive vice president directly owned 45,742 shares of the company’s stock, valued at $4,366,073.90. This trade represents a 19.33% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Michael Henry Fiore sold 1,781 shares of the business’s stock in a transaction that occurred on Tuesday, October 7th. The shares were sold at an average price of $88.21, for a total value of $157,102.01. Following the completion of the transaction, the executive vice president directly owned 49,795 shares of the company’s stock, valued at $4,392,416.95. The trade was a 3.45% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 17,240 shares of company stock valued at $1,640,164. Company insiders own 1.50% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have commented on HQY shares. Jefferies Financial Group boosted their target price on shares of HealthEquity from $130.00 to $134.00 and gave the stock a “buy” rating in a report on Wednesday, September 3rd. Weiss Ratings reissued a “hold (c+)” rating on shares of HealthEquity in a research report on Wednesday, October 8th. Barrington Research restated an “outperform” rating and issued a $125.00 target price on shares of HealthEquity in a research note on Thursday, December 4th. Royal Bank Of Canada upped their price target on HealthEquity from $109.00 to $110.00 and gave the stock an “outperform” rating in a research report on Wednesday, September 3rd. Finally, Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a $120.00 price objective on shares of HealthEquity in a research report on Friday, December 5th. Two research analysts have rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $120.27.

HealthEquity Price Performance

Shares of NASDAQ:HQY opened at $93.48 on Friday. HealthEquity, Inc. has a twelve month low of $74.07 and a twelve month high of $116.65. The company has a current ratio of 4.13, a quick ratio of 4.13 and a debt-to-equity ratio of 0.46. The company has a market cap of $7.99 billion, a PE ratio of 42.88, a price-to-earnings-growth ratio of 1.34 and a beta of 0.18. The company’s 50 day moving average is $97.28 and its 200 day moving average is $95.88.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings data on Wednesday, December 3rd. The company reported $1.01 earnings per share for the quarter, topping analysts’ consensus estimates of $0.90 by $0.11. HealthEquity had a net margin of 14.86% and a return on equity of 12.94%. The firm had revenue of $322.16 million for the quarter, compared to analyst estimates of $320.92 million. During the same quarter in the prior year, the business earned $0.78 earnings per share. The business’s quarterly revenue was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. On average, sell-side analysts forecast that HealthEquity, Inc. will post 2.32 EPS for the current year.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.